Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE RightBio Metrics
Pioneering medical device developer earns three FDA and CE Mark approvals for innovative bio fluid measurement technologies that assist in verifying proper nasogastric tube placement
PHOENIX, June 11, 2014 /PRNewswire/ -- RightBio Metrics, an emerging leader in advanced fluid measurement technologies, today announces the availability of three new products after receiving both FDA and CE Mark approvals to distribute their point-of-care diagnostic devices. The approved devices, designed to provide safer nasogastric (NG) tube placement and accurate gastric acidity measurement using an innovative in vitro pH indicator include, RightSpot pH Indicator, RightSpot Infant pH Indicator and RightLevel pH Detector.
Housed under the brand RightpH, the technologies accurately measure bio fluids at the bedside to enhance the speed and quality of medical treatment. They are safer, cleaner and more accurate than pH paper test strips used today, giving clinicians additional confidence in NG tube placement, and treatment decisions, without incurring substantial costs to verify placement using X-rays or fumbling with messy manual paper tests.
The RightSpot pH Indicator and RightSpot Infant pH Indicator are small, non-invasive devices that are used to verify gastric acidity to avoid misplacement of NG feeding/suction tubes and percutaneous endoscopic gastrostomy (PEG) tubes. The third device, the RightLevel pH Detector, quickly measures stomach pH levels of critically ill patients to aid in proper medication dosage for treating gastric ulcers and bleeding. All three products have received CLIA Waived status, which means the FDA has classified them as simple laboratory examinations and procedures that have an insignificant risk of an erroneous result, which makes it easier for hospitals to perform onsite and maintain per CAP regulations.
"As an emergency room physician, I experienced firsthand the devastating effects of improper NG tube placement and uncertainty about treatment-critical metrics due to antiquated technology. Seeing patients put at unnecessary risk ignited my passion to make much needed fluid measurement technology improvements," said Paul Gilbert, MD, co-founder and president, RightBio Metrics.
Roughly 12.6 million NG tubes were placed in 2012 in the U.S. alone and studies show between two and four percent were misplaced. Misplaced tubes are typically misguided into the lungs causing significant morbidity and mortality and costing medical providers millions of dollars. In fact, from 2001 to 2011, medical providers in the Chicago area paid more than 10 million dollars to resolve lawsuits filed for injuries and deaths caused by misplaced NG feeding and suction tubes.
"Care providers are continuously looking for solutions that combine quality improvement with financial responsibility. RightpH devices help clinicians put science into decision-making and increase certainty about tube placement and treatment decisions without losing critical time," stated Gilbert. "RightpH indicators also help hospitals save important resources by lowering the risk of readmission and malpractice claims, which position themselves as leaders in patient safety and clinician practice conditions."
Gilbert added, "In medicine, quick decisions have to be made in treatment environments that often do not permit the use of expensive equipment. While pH measurement has become standard practice to ensure better treatment, RightpH offers the first safe and efficient technologies for easy pH measurement. We're excited to equip providers with these valuable tools to help eliminate any further NG tube misplacements or mistreatment."
About RightBio Metrics
RightBio Metrics is an emerging leader in advanced bio fluid measurement technologies. The company's RightpH line of products accurately measure bodily fluid metrics to enhance the speed and quality of medical treatment at the point-of-care and reduce healthcare costs associated with mistreatment and alternative verification methods. To learn more, please visit RightBioMetrics.com.
©2012 PR Newswire. All Rights Reserved.